Ulrik Narbe

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

Thomas Bachelot, Eva Ciruelos, Fabio Puglisi et al. · Annals of Oncology · 2019 · 113 citations · Full text

Medicine, Oncology, Pharmacology +17

Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

David Miles, Eva Ciruelos, Fabio Puglisi et al. · Annals of Oncology · 2021 · 89 citations · Full text

Medicine, Oncology, Pharmacology +17

Invasive lobular carcinoma of the breast: long-term prognostic value of Ki67 and histological grade, alone and in combination with estrogen receptor

Ulrik Narbe, Pär‐Ola Bendahl, Dorthe Grabau et al. · SpringerPlus · 2014 · 21 citations · Full text

Medicine, Oncology, Surgery +15

The Distribution of Circulating Tumor Cells Is Different in Metastatic Lobular Compared to Ductal Carcinoma of the Breast—Long-Term Prognostic Significance

Ulrik Narbe, Pär‐Ola Bendahl, Kristina Aaltonen et al. · Cells · 2020 · 16 citations · Full text

Medicine, Cancer Biology, Oncology +17

St Gallen 2019 guidelines understage the axilla in lobular breast cancer: a population-based study

Ulrik Narbe, P-O Bendahl, Mårten Fernö et al. · British journal of surgery · 2021 · 11 citations · Full text

Medicine, Oncology, Surgery +17